Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Becotatug Vedotin and Pucotenlimab in Locally Advanced HNSCC
NCT07915258Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2027
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of becotatug vedotin, pucotenlimab in head and neck squamous cell carcinoma (HNSCC), sponsored by Sun Yat-sen University. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
becotatug vedotinpucotenlimab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07915258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07915258.